Drugs / Molsidomine
last change Sep 2014 re-read 2 minutes ago

Molsidomine

Small molecule

Developed for
myocardial ischemia
Investigated by
Luzerner Kantonsspital · Therabel Pharma SA/NV

Trials 2 · a red edge is where a trial was stopped

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT01363661 Jun 2011 → Sep 2014 atherosclerosis Therabel Pharma SA/NV Completed No outcome recorded
Phase not applicable1 trial
NCT00382421 Feb 1992 → Apr 2006 myocardial ischemia Luzerner Kantonsspital Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as molsidomine Molsidomine 16 mg tablet, per os, once a day” NCT01363661
1

NCT00382421

Known as CAS 276 ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as Coruno Coruno (molsidomine 16 mg tablet; per os; once daily)” NCT01363661
Known as Corvasal ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as Corvaton mite ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as Corvaton ret ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as Molsidomina ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as Morsydomine ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Known as NSC-757398 ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455
Modality Small molecule CHEMBL1329455
Route Oral “Molsidomine 16 mg tablet, per os, once a day” NCT01363661